Northern Trust Corp Graybug Vision, Inc. Transaction History

Northern Trust Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$3.18 - $5.17 $13,187 - $21,439	4,147 Added 34.68%	16,104 $53,000
Q2 2021 Aug 13, 2021	SELL	$3.53 - $6.1 $207,355 - $358,320	-58,741 Reduced 83.09%	11,957 $65,000
Q1 2021 May 12, 2021	SELL	$5.55 - $35.0 $20,018 - $126,245	-3,607 Reduced 4.85%	70,698 $393,000
Q4 2020 Feb 11, 2021	BUY	$13.05 - $33.93 $969,680 - $2.52 Million	74,305 New	74,305 $2.16 Million

Ticker GRAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,517,700
Market Cap $63.5M
Description
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the t...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.